Prelude Therapeutics cut the ribbon on its new headquarters on Friday morning, signaling the next chapter in the company's growth.
MRA Group, the developer behind the Chestnut Run Innovation and Science Park (CRISP), has secured $63 million in financing for the project.
Business growth and attracting a workforce were key themes central to the inaugural State of the New Castle County event on Wednesday, and speakers shared how it touches the future warehouses in Claymont to the ...
The first Delaware DNA conference hosted by the Delaware BioScience Association drew about 350 people to network and listen to panels.
People on the Move is a rundown of recent hirings, promotions, appointments and other notable movements by professionals in the state. If you’re interested in submitting an entry, please contact […]
Delaware Business Times highlights an annual list of individuals as “People to Watch” in the new year as we believe they will leave a mark on their industries or communities. […]
WILMINGTON – A recent state report underlined the growing importance and impact of pharmaceutical, biotechnology and health care research firms collectively known as life sciences in Delaware, an industry that […]
WILMINGTON – Cancer treatment research company Prelude Therapeutics has signed a major lease for its future headquarters at the Chestnut Run Innovation and Science Park (CRISP), the first new tenant […]
WILMINGTON – Pennsylvania-based developer MRA Group closed on Tuesday its acquisition of a large chunk of DuPont’s Chestnut Run headquarters campus, which it will turn into a $500 million research […]
WILMINGTON – Just a few months after calling off its proposed sale to Delle Donne & Associates, DuPont has announced that it will sell its laboratories at its Chestnut Run […]
Premier Digital Partners
© 2024 Delaware Business Times
